Cytokinetics CYTK
NASDAQ CYTK
$56.18 +1.04 (+1.89%)
At close: Nov 10, 2026 · 4:00 PM EST

Cytokinetics (CYTK) Gross Profit (2018 - 2026)

Updated

Cytokinetics (CYTK) recorded Gross Profit of $47.1 million in Q3 2026, compared with $1.94 million a year earlier and up 81.9% from the prior quarter.

Analysis

Cytokinetics (CYTK) Gross Profit (2018 - 2026) Analysis & Trends

On a TTM basis, Cytokinetics' Gross Profit came in at $94.13 million as of Sep 30, 2026.

  • The Q3 2026 figure is the highest quarterly Gross Profit since Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cytokinetics 7.83 Bn 3.24 Bn 47.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 47.10 Mn
Jun 30, 2026 25.89 Mn
Mar 31, 2026 19.20 Mn
Dec 31, 2025 -61.60 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 66.77 Mn
Mar 31, 2025 1.58 Mn
Dec 31, 2024 1.55 Mn
Dec 31, 2023 1.00 Mn
Mar 31, 2023 2.11 Mn
Dec 31, 2022 1.96 Mn
Jun 30, 2022 1.97 Mn
Dec 31, 2021 10.57 Mn
Sep 30, 2021 437,000.00
Dec 31, 2020 6.72 Mn
Sep 30, 2020 5.19 Mn
Sep 30, 2018 1.92 Mn
Jun 30, 2018 1.54 Mn
Mar 31, 2018 1.68 Mn
API Access

Cytokinetics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CYTK&period=max&api_key=YOUR_API_KEY